| Date |
Title |
Rating |
| 2011-05-31 |
FDA approves Oceana's Solesta for treatment of fecal incontinence |
None |
| 2011-05-31 |
Defiante, Dyax expand KALBITOR partnership to treat hereditary angioedema |
None |
| 2011-05-31 |
YM BioSciences' CYT387 receives European Commission positive opinion for Orphan Drug Designation |
None |
| 2011-05-31 |
Takeda, Affymax submit peginesatide NDA to FDA for treatment of anemia linked with chronic renal failure |
None |
| 2011-05-31 |
BioAlliance's appeals in SpePharm litigation rejected |
None |
| 2011-05-31 |
Scientists develop carbohydrate-based vaccine against C. difficile infection |
None |
| 2011-05-31 |
Cancer drug helps prevent hypertensive heart disease |
None |
| 2011-05-30 |
National Pharmacovigilance Programme to increase awareness about benefits of adverse event reporting |
None |
| 2011-05-30 |
Oceana Therapeutics receives FDA approval for Solesta injectable gel to treat fecal incontinence |
None |
| 2011-05-30 |
Optimer receives FDA approval for Dificid tablets to treat C. difficile-associated diarrhea |
None |
| 2011-05-29 |
Cholesterol drug Niaspan fails to protect heart: Study |
None |
| 2011-05-29 |
Flu vaccines at the ready this season |
None |
| 2011-05-29 |
Efficacy of Abbott cholesterol drug in question |
4 |
| 2011-05-27 |
Emergent in active discussions with U.S. government for multi-year supply of BioThrax to the SNS |
None |
| 2011-05-27 |
Blue Cross and Blue Shield FEP pharmacy benefit management program awarded to CVS Caremark |
None |
| 2011-05-27 |
Nature special issue focuses on vaccines |
None |
| 2011-05-27 |
Study: Cardiovascular disease may be under treated in rheumatoid arthritis patients |
None |
| 2011-05-27 |
IDF applauds Representatives for Medicare IVIG Access Act |
None |
| 2011-05-27 |
Sanofi-Aventis, Medtronic under scrutiny in press reports |
None |
| 2011-05-27 |
Two new hepatitis C drugs effectively improve cure rates of African Americans |
1 |
| 2011-05-27 |
Mylan plans to change name of Matrix Laboratories |
None |
| 2011-05-27 |
Leukemia, psoriasis drugs may treat vascular diseases |
None |
| 2011-05-27 |
Research sheds light on how painkillers could prevent or slow down cancer growth |
None |
| 2011-05-27 |
Abiraterone acetate effective for men with advanced prostate cancer |
None |
| 2011-05-27 |
Omega-3 fatty acids reduce risk of heart attack in stent patients |
None |
| 2011-05-27 |
Long-term exposure to estrogen increases high blood pressure in women |
5 |
| 2011-05-27 |
Pro-Pharmaceuticals announces name change to Galectin Therapeutics |
None |
| 2011-05-27 |
MAP Pharmaceuticals submits LEVADEX NDA to FDA for treatment of migraine in adults |
None |
| 2011-05-26 |
Invida announces launch of novel atopic dermatitis symptomatic treatment |
None |
| 2011-05-26 |
Gerber Products receives first qualified health claim from FDA for infant formulas |
None |
| 2011-05-26 |
HPV vaccination does not affect rate of disease flares in patients with SLE, study finds |
None |
| 2011-05-26 |
IPS examines access to medicine in Malawi |
None |
| 2011-05-26 |
Studies find antibiotics overused for children with asthma, urinary tract infections |
None |
| 2011-05-26 |
Nurses can play vital role in increasing patients' adherence to cancer-fighting medication |
None |
| 2011-05-26 |
U.S. District Court grants temporary restraining order in Amylin's litigation against Lilly |
None |
| 2011-05-26 |
Paxil and Pravachol in combination cause unexpected increase in blood glucose levels |
None |
| 2011-05-26 |
Metyrapone reduces brain's ability to re-record negative emotions associated with recalling painful memories |
None |
| 2011-05-26 |
Study shows positive link between percentage of motile sperm and serum vitamin D levels |
None |
| 2011-05-26 |
Lx Therapies, BioCis partner to form Laurantis Pharma |
None |
| 2011-05-25 |
Scarcity of resources calls for equitable distribution system for novel HCV treatment |
1 |
| 2011-05-25 |
Comtex SmarTrend ranks POZEN as second most efficient pharmaceutical company |
None |
| 2011-05-25 |
Pharmaceutical Executive's Ad Stars, DTC Perspectives recognize Auxilium and Heartbeat work |
None |
| 2011-05-25 |
AFP examines expansion of Indian drug companies in South Africa |
None |
| 2011-05-25 |
Study provides insight into effective treatments for autism spectrum disorder, seizures |
None |
| 2011-05-25 |
BPD expands existing bioprocess and scale-up laboratory in Poway, CA |
1 |
| 2011-05-25 |
New combination therapy eradicates acute lymphoblastic leukemia in children, older adults |
None |
| 2011-05-25 |
3M Skin and Wound Care introduces Tegaderm Diamond Dressing with Comfort Adhesive Technology |
2.5 |
| 2011-05-24 |
Study offers hope for reducing incidence of AIDS with potential preventive vaccine |
None |
| 2011-05-24 |
Provepharm obtains European marketing authorization for its Methylthioninium Chloride Proveblue |
None |
| 2011-05-24 |
New study finds drug's side effect labeling have ballooned in size |
None |
| 2011-05-24 |
Scientific evidence supports benefits of sunscreen usage to prevent skin cancer |
None |
| 2011-05-24 |
Fluorinated glucosamine blocks synthesis of key sugar linked to skin inflammation, cancer progression |
None |
| 2011-05-24 |
Exosome Diagnostics announces expansion of scientific advisory board |
None |
| 2011-05-24 |
IPS examines subsidized malaria drugs in Kenya |
None |
| 2011-05-24 |
Long-term, regular acetaminophen use may be associated with lower prostate cancer risk |
None |
| 2011-05-24 |
Vertex Incivek receives FDA approval for treatment of chronic hepatitis C |
None |
| 2011-05-24 |
FDA approves Taro's ANDA for Cetirizine Hydrochloride Oral Solution |
None |
| 2011-05-23 |
Key U.S. patents increase commercial rights and clinical indications |
None |
| 2011-05-23 |
FDA approves Amneal's generic Furadantin |
None |
| 2011-05-23 |
Vertex receives FDA approval for INCIVEK to treat hepatitis C |
3 |
| 2011-05-23 |
Nano-complex pre-meal dietary supplement can reduce fat and sugar absorption in the body |
3 |
| 2011-05-23 |
Mylan introduces Divalproex Sodium Capsules for treatment of seizures |
None |
| 2011-05-23 |
Novel compound could become an effective alternative to common narcotic analgesics |
None |
| 2011-05-23 |
Sosei to introduce NorLevo oral emergency contraceptive in Japan |
None |
| 2011-05-22 |
Verizon Wireless and Medco unveil mobile medication app with real-time patient-specific drug safety |
None |
| 2011-05-22 |
Avandia withdrawal from shelves by November: FDA |
None |
| 2011-05-21 |
FDA approves SUTENT for treatment of pancreatic NET |
None |
| 2011-05-21 |
Many 'legal high' drugs sold on the internet do not contain ingredients they claim |
None |
| 2011-05-21 |
Some cancer patients go without drugs because of high cost |
None |
| 2011-05-21 |
U.S. District Court grants Cephalon Temporary Restraining Order for generic AMRIX |
None |
| 2011-05-21 |
New study raises doubts about benefits of ezetimibe in patients suffering from high LDL cholesterol |
5 |
| 2011-05-21 |
Edurant receives FDA approval for treatment of HIV-1 infection |
None |
| 2011-05-21 |
Local production of pharmaceuticals could improve access in developing countries, U.N. report says |
None |
| 2011-05-21 |
Feeding SimplyThick to premature infants may cause NEC, warns FDA |
None |
| 2011-05-21 |
FDA approves Sutent for patients with progressive neuroendocrine cancerous tumors in pancreas |
None |
| 2011-05-20 |
Most paediatric paracetamol prescriptions fails to comply with BNFc recommendations |
None |
| 2011-05-20 |
EMA CHMP recommends conditional marketing authorization of FAMPYRA |
None |
| 2011-05-20 |
EMA CHMP recommends positive opinion for marketing authorization of Amgen's XGEVA |
None |
| 2011-05-20 |
Merck's VICTRELIS receives European CHMP positive opinion for treatment of chronic HCV genotype 1 infection |
None |
| 2011-05-20 |
EMA CHMP issues positive opinion for marketing approval of BENLYSTA |
None |
| 2011-05-20 |
Cholesterol drug may help treat mitochondrial diseases |
1 |
| 2011-05-20 |
'No magic pill' for HIV prevention |
None |
| 2011-05-20 |
Abbott appreciates FDA Advisory Committee recommendations to retain Trilipix indication for mixed dyslipidemia |
None |
| 2011-05-20 |
Naltrexone improves clinical, inflammatory activity in Crohn's disease patients |
None |
| 2011-05-20 |
Study: Costs get in way of cancer patients refilling their prescriptions |
None |
| 2011-05-19 |
Medical food resolves metabolic syndrome and cardiovascular risk factors |
None |
| 2011-05-19 |
Viagra helps reduce clinical signs of multiple sclerosis |
None |
| 2011-05-19 |
AVAC calls on donors, policy makers to strengthen support for AIDS vaccine research |
None |
| 2011-05-19 |
USPTO grants four key patents for Alvine's proteases to detect celiac disease |
None |
| 2011-05-19 |
Study: 10% of cancer patients fail to fill initial oral oncolytic prescriptions |
None |
| 2011-05-19 |
Modified vitamin A drug may help prevent age-related macular degeneration |
None |
| 2011-05-19 |
Generic drugs to rule the market in the near future: Experts |
None |
| 2011-05-19 |
Panel votes 20-0 for reformed labeling of kids’ pain & fever relieving medication |
None |
| 2011-05-19 |
Aspirin, simvastatin not effective in combating pulmonary artery hypertension |
4 |
| 2011-05-19 |
APP receives FDA approval to market Gemcitabine HCI for Injection, USP in 2 g dosage |
None |
| 2011-05-19 |
Alemtuzumab as effective as other more expensive immune suppressants for kidney transplants |
2 |
| 2011-05-19 |
New breast cancer biomarker may help identify women's response to tamoxifen |
None |
| 2011-05-19 |
Global health partnership announces first-, second-line AIDS drugs price reductions in developing world |
None |
| 2011-05-18 |
Study reveals weakness of pharmacies' clinical decision support software in evaluating drug-drug interactions |
None |
| 2011-05-18 |
Haiti presents plan to immunize 90 percent of newborns |
None |
| 2011-05-18 |
Silodosin helps reduce chronic prostatitis in men |
2.5 |
| 2011-05-18 |
Study: 80% of U.S. physicians use Herceptin for HER2-positive metastatic gastric cancer treatment |
None |
| 2011-05-18 |
UW C4C, Pharmigene execute licensing agreement for warfarin personalized medicine technology |
None |
| 2011-05-18 |
Bill Gates calls for greater immunization efforts in World Health Assembly address |
None |
| 2011-05-18 |
Two drug makers will disclose prices they charge UNICEF for vaccines |
None |
| 2011-05-18 |
Study finds three-month TB treatment regimen just as effective as standard longer course |
None |
| 2011-05-18 |
Teva, ERYtech Pharma sign long term distribution agreement for Graspa in Israel |
None |
| 2011-05-18 |
Opinion: Study will unite HIV advocates, add funding pressure to Obama administration |
None |
| 2011-05-17 |
Daiichi Sankyo, Regency Therapeutics launch SPRIX Nasal Spray for severe pain |
None |
| 2011-05-17 |
Gastroenterologists have limited knowledge of appropriate immunizations for IBD patients, study finds |
None |
| 2011-05-17 |
Pfizer seeks U.S. FDA, Japanese MHLW approval for crizotinib NDA to treat ALK-positive advanced NSCLC |
None |
| 2011-05-17 |
Nordic Naturals' dietary supplements earn NSF certification |
1 |
| 2011-05-17 |
Antiretrovirals important to protect HIV-positive children from measles |
None |
| 2011-05-17 |
World Health Assembly begins in Geneva |
None |
| 2011-05-17 |
Novel topically-applied molecular microbicide protects women against HIV infection |
None |
| 2011-05-17 |
Eli Lilly responds to Amylin's exenatide lawsuit |
None |
| 2011-05-17 |
Anti-inflammatory drug celecoxib reacts with protein and induces liver cancer cells to commit suicide |
None |
| 2011-05-17 |
Epichem signs exclusive distributor agreement with AR Brown |
None |
| 2011-05-17 |
Benitec raises AU$8 million for gene silencing therapeutics |
None |
| 2011-05-17 |
Abcc10 might help counter resistance and extend effectiveness of anticancer drugs |
None |
| 2011-05-17 |
GPSA, Sanofi partner to develop and commercialize GBR 500 for inflammatory disease treatment |
None |
| 2011-05-17 |
Perrigo's ANDA for generic Zantac 150 receives FDA final approval to treat heartburn |
None |
| 2011-05-17 |
FDA nod for hepatitis C drug |
None |
| 2011-05-17 |
Opinion: New HIV infections more expensive than providing antiretroviral drugs to existing patients |
None |
| 2011-05-16 |
FDA warns consumers about look like antimicrobial dietary supplements |
None |
| 2011-05-16 |
Mylan introduces Bromfenac Ophthalmic Solution for cataract postoperative inflammation treatment |
None |
| 2011-05-16 |
Amylin files lawsuit against Eli Lilly for improper commercialization of exenatide |
None |
| 2011-05-16 |
Study finds no potential cardiovascular risks of ADHD medications in children, adolescents |
None |
| 2011-05-16 |
Study: HIV treatment drugs slash transmission risk |
None |
| 2011-05-16 |
Formoline L112 effectively aids weight loss |
4 |
| 2011-05-16 |
Counterfeit medicines posing increasing risk to patients worldwide, U.N. agency says |
None |
| 2011-05-16 |
Karo Bio symposium to discuss research on ER-beta and therapeutic applications |
None |
| 2011-05-16 |
Australian TGA approves Biogen Idec's FAMPYRA to improve walking ability in patients with MS |
None |
| 2011-05-16 |
pSivida resubmits ILUVIEN NDA to FDA for diabetic macular edema treatment |
None |
| 2011-05-16 |
Vitamin D may improve exercise capacity, respiratory muscle strength in COPD patients |
4 |
| 2011-05-16 |
Obese men may face high risk of prostate cancer progression |
None |
| 2011-05-16 |
Mylan introduces Cyclobenzaprine HCl ER Capsules, a muscle relaxant |
None |
| 2011-05-16 |
Merck receives FDA approval for Victrelis to treat chronic hepatitis C |
None |
| 2011-05-13 |
Scientists 'tinker' with HIV drug chemistry hoping to reduce costs |
None |
| 2011-05-13 |
China's SFDA approves TPI anti-diabetic drug Gliclazide |
None |
| 2011-05-13 |
Mylan introduces Risperidone Orally Disintegrating Tablets for schizophrenia treatment |
None |
| 2011-05-13 |
Patients with sickle cell disease may require higher, frequent doses of morphine |
None |
| 2011-05-13 |
Rethink praises Ontario's decision to provide breast cancer patients with access to Herceptin |
None |
| 2011-05-13 |
Majority of high-risk heart disease patients have poor adherence to statin treatment |
None |
| 2011-05-13 |
Hydroxyurea safe and effective for infants, toddlers with sickle-cell disease |
None |
| 2011-05-12 |
Researchers help explain why smart drugs are not effective in some cancer patients |
None |
| 2011-05-12 |
ETI finalizes proprietary progesterone formulations for Traumatic Brain Injury |
None |
| 2011-05-12 |
Linguamatics releases I2E. Version 3.2 software for pharmaceutical companies |
None |
| 2011-05-12 |
New organocatalyst now available for drug development industry |
None |
| 2011-05-12 |
Health Canada approves EMEND IV formulation to prevent chemotherapy-induced nausea, vomiting |
None |
| 2011-05-12 |
Antiretroviral therapy can reduce risk of HIV transmission in couples |
None |
| 2011-05-12 |
Losartan therapy improves muscle injury regeneration and prevents disuse atrophy |
None |
| 2011-05-12 |
Scientists develop promising vaccine formulations to treat methamphetamine addiction |
None |
| 2011-05-12 |
VGTI, OHSU's new vaccine candidate may fight against HIV |
None |
| 2011-05-12 |
Researchers look for surrogate endpoints to predict early benefit of cancer drugs |
None |
| 2011-05-12 |
FDA accepts EffRx NDA for EX101 to treat osteoporosis |
None |
| 2011-05-12 |
Neogenix Oncology to receive European Patent for NEO-301 antibody for treatment of pancreatic cancer |
None |
| 2011-05-12 |
FDA accepts Insys NDA for Fentanyl SL Spray to treat breakthrough cancer pain |
None |
| 2011-05-12 |
ViroPharma, Halozyme sign license deal to develop Cinryze against hereditary angioedema |
None |
| 2011-05-11 |
Injecting botox in 'trigger points' of pericraneal and neck muscles reduces migraine frequency |
None |
| 2011-05-11 |
SAFC, Oncolytics Biotech sign commercial supply agreement for REOLYSIN |
None |
| 2011-05-11 |
AspirinWorks Test now available in greater Boston and surrounding area |
None |
| 2011-05-11 |
Baylor has now patented new polarimeter that could prove useful in pharmaceuticals |
None |
| 2011-05-11 |
Amylin, JDRF collaborate to investigate combination therapy for type 1 diabetes treatment |
None |
| 2011-05-11 |
NAA calls for immediate Congressional hearings and scientific investigation into autism-vaccine link |
5 |
| 2011-05-11 |
U.S. biopharmaceutical companies to benefit from Almac's European Product Launch workshop |
None |
| 2011-05-11 |
EMD Millipore inaugurates new Shanghai Biopharmaceutical Technical Center |
None |
| 2011-05-11 |
Adherence to disease-modifying drugs is low in patients with multiple sclerosis |
None |
| 2011-05-11 |
Genentech submits vemurafenib NDA for BRAF V600 mutation-positive metastatic melanoma |
None |
| 2011-05-11 |
BioAlliance Pharma enters license deal with Sosei to commercialize Loramyc in Japan |
None |
| 2011-05-11 |
Sosei acquires rights to Loramyc in Japan from BioAlliance Pharma |
None |
| 2011-05-11 |
Novel two-drug combination cures young patient with extensively drug-resistant tuberculosis |
None |
| 2011-05-11 |
Govt. audit finds antipsychotic drugs often overused in nursing homes |
None |
| 2011-05-11 |
Plexxikon seeks vemurafenib marketing approval from FDA and EMA for melanoma treatment |
None |
| 2011-05-11 |
NCL launches new public education campaign on medication adherence |
None |
| 2011-05-11 |
Major European conference on Nanomedicine to take place in Basel, Switzerland |
None |
| 2011-05-11 |
Allos, Mundipharma enter strategic collaboration to co-develop FOLOTYN |
None |
| 2011-05-10 |
AOBO's ZD Pill and CWJ Tablet receive Chinese approval for sales in Hong Kong |
None |
| 2011-05-10 |
HIV drugs can be used to target malaria and other parasitic diseases |
None |
| 2011-05-10 |
Study confirms LcS-fermented milk reduces fever linked with acute norovirus gastroenteritis |
None |
| 2011-05-10 |
Geron comments on recent European telomerase peptide cancer vaccine patents |
None |
| 2011-05-10 |
Study: Personality impacts medication adherence behaviour |
None |
| 2011-05-10 |
Pepscan, Phylogica collaborate for Phylomer peptide lead optimisation |
None |
| 2011-05-10 |
biocrea and Pfizer jointly presented details on novel PDE10 inhibitors |
None |
| 2011-05-10 |
ASA survey shows more than 90% of respondents experience anesthesia drug shortage |
None |
| 2011-05-10 |
Mathematical approach can make combination vaccines more affordable for developing countries |
None |
| 2011-05-10 |
Forest subpoenaed over hypertension medications |
None |
| 2011-05-10 |
Research finds 'no safe window' for painkiller use among heart attack survivors |
None |
| 2011-05-09 |
KAEL-GemVax wins European telomerase patent challenge |
None |
| 2011-05-09 |
OncoSec's tumor-destroying, tissue-sparing drug/device system profiled in Medical Device Daily |
None |
| 2011-05-09 |
Ideal psychotropic drug may cause physical dependence |
2.2 |
| 2011-05-09 |
Merrimack, PharmaEngine collaborate to develop and commercialize PEP02 in Asia and Europe |
None |
| 2011-05-09 |
Heptares, Shire sign deal to develop novel A2A antagonist for CNS disease treatment |
None |
| 2011-05-09 |
Merrimack acquires development and commercialization rights to MM-398 in Europe, Asia |
None |
| 2011-05-09 |
Elan Drug Technologies, Alkermes merge to form new company in Ireland |
None |
| 2011-05-09 |
Best Practices' report provides marketing, branding strategies for expanding multi-drug portfolio |
None |
| 2011-05-09 |
Adalimumab remains in newborn's bloodstream for at least three months |
None |
| 2011-05-09 |
Mithridion's MCD-386CR receives Orphan Drug designation from FDA for PSP treatment |
None |
| 2011-05-07 |
Cegedim Relationship Management's co-pay savings card programs presented at PMSA conference |
None |
| 2011-05-07 |
Current Opinion in Immunology journal publishes Inovio's article on DNA vaccines |
None |
| 2011-05-07 |
Medical societies still 'welcome' drug company support |
None |
| 2011-05-07 |
Study finds 4.5 million outpatient visits yearly due to adverse drug effects |
None |
| 2011-05-07 |
Alza files patent infringement suit against Impax in connection with Concerta |
None |
| 2011-05-07 |
Caisse des Dépôts, sanofi-aventis sign memorandum of understanding for Caisse des Dépôts Investment in Biocitech life science technology park |
None |
| 2011-05-07 |
FDA approves Afinitor for treatment of progressive neuroendocrine tumors in the pancreas |
None |
| 2011-05-07 |
Novartis receives FDA approval for Afinitor to treat pancreatic neuroendocrine tumors |
None |
| 2011-05-06 |
Inhalation therapy might halt and reverse progression of pulmonary arterial hypertension |
None |
| 2011-05-06 |
SaveRxCanada.com reveals top reasons why U.S. customers select Canadian pharmacy |
None |
| 2011-05-06 |
Springer author earns ESCMID recognition for work in clinical microbiology and infectious diseases |
None |
| 2011-05-06 |
SAS Health Care & Life Sciences Executive Conference to discuss clinical research best practices |
None |
| 2011-05-06 |
TB medication variations in private markets could harm treatment efforts, study says |
None |
| 2011-05-06 |
Patent expiries, generic pricing policies may be factors in slow drug spending growth |
None |
| 2011-05-06 |
Savings projected from 'emerging' generic drugs |
None |
| 2011-05-06 |
FDA approves Novartis' Afinitor tablets for pancreatic NET treatment |
None |
| 2011-05-05 |
New drugs need to provide more data on how they compare with existing ones: Study |
None |
| 2011-05-05 |
Asthma ‘pill-a-day’ shows similar effectiveness as inhalers: Study |
None |
| 2011-05-05 |
Pfizer’s Revatio receives European Commission approval for pediatric treatment of pulmonary arterial hypertension |
None |
| 2011-05-05 |
PhotoMedex introduces DNA Damage Control sunscreens |
None |
| 2011-05-05 |
Mylan launches Oxycodone and Aspirin Tablets for treatment of severe pain |
None |
| 2011-05-05 |
FDA releases final guidance to firms that market OTC drug products |
None |
| 2011-05-05 |
Devrom is effective for eliminating flatulence, stool odor issues |
4.6 |
| 2011-05-05 |
S*BIO regains North American, European rights to novel JAK2 inhibitors from Onyx |
None |
| 2011-05-05 |
NBA Cares, SAHM and Tulsa Shock guard partner for teen vaccine awareness campaign |
None |
| 2011-05-05 |
UCF to develop safe, inexpensive and effective polio vaccine |
None |
| 2011-05-05 |
Study: Bisphosphonates can cause fatigue fractures |
None |
| 2011-05-05 |
Leukotriene antagonists can serve as effective alternative to conventional asthma treatment |
None |
| 2011-05-05 |
Rockland produces new Anti-NF-κB monoclonal antibody |
None |
| 2011-05-05 |
TGen licenses ONCO-101 cancer drug to Syracuse |
None |
| 2011-05-04 |
Durata receives positive EMA Scientific Advice on dalbavancin clinical development plan |
None |
| 2011-05-04 |
Affitech, Cancer Research Technology sign deal to advance therapeutic antibodies |
None |
| 2011-05-04 |
Cocaine and nicotine employ similar mechanisms to induce synaptic plasticity in brain |
None |
| 2011-05-04 |
Study measures cost-effectiveness of trauma drug published in PLoS One |
None |
| 2011-05-04 |
Yale, Debiopharm partner to develop and commercialize Debio 1036 for inflammatory diseases |
None |
| 2011-05-04 |
NCPA explains how PBM tools can reduce costs in Texas, other states |
None |
| 2011-05-04 |
FTC, FDA take action on unproven STD drug products |
None |
| 2011-05-04 |
Ecstasy may cause long-term brain damage |
None |
| 2011-05-04 |
AHF cautions against fast track FDA-approval for expanded use of Gilead’s Truvada |
None |
| 2011-05-03 |
Merial, GenVec extend deal to develop and commercialize foot-and-mouth disease vaccine |
None |
| 2011-05-03 |
Study: Dual medications do not hasten recovery from depression |
None |
| 2011-05-03 |
NanoViricides' FluCide drug candidate greatly reduces lung viral load in animals |
None |
| 2011-05-03 |
Lopinavir can combat HPV-related cervical cancer |
2.7 |
| 2011-05-03 |
New study: Text-heavy labels can reduce acetaminophen overdose |
None |
| 2011-05-03 |
Calcium and vitamin D intake before bone density test can reduce risk of osteoporosis |
None |
| 2011-05-03 |
AHA recommends Omega-3 EPA/DHA intake for individuals with elevated triglyceride levels |
None |
| 2011-05-03 |
CTI to re-submit pixantrone NDA to FDA's Office of New Drugs for re-review |
None |
| 2011-05-03 |
Desirudin more effective for VTE prevention in patients with renal impairment |
None |
| 2011-05-03 |
Althea enters commercial drug supply agreement with Biotest |
None |
| 2011-05-03 |
Winner Medical's PurCotton products introduced at MICF 2011 |
None |
| 2011-05-03 |
JPO issues patent to Silence Therapeutics' RNAi technology |
None |
| 2011-05-03 |
Boehringer Ingelheim, Eli Lilly receive FDA approval for linagliptin to treat type 2 diabetes |
None |
| 2011-05-03 |
HIV drugs may also combat parasitic diseases: Study |
None |
| 2011-05-03 |
More HIV infections linked to injection drug use in East Africa, report finds |
None |
| 2011-05-03 |
Statins can help reduce lung damage in severe abdominal sepsis |
5 |
| 2011-05-03 |
FDA approves Perrigo's Minoxidil Foam, a generic version of Men's Rogaine Foam |
None |
| 2011-05-03 |
Oragenics announces availability of oral care probiotics for children and adults |
None |
| 2011-05-03 |
AstraZeneca receives FDA approval for NEXIUM I.V. to treat GERD with erosive esophagitis |
3.7 |
| 2011-05-03 |
Sanofi Pasteur, EnGen Bio and Dyadic Nederland sign research deal for vaccine development |
None |
| 2011-05-03 |
Hebei Aoxing Pharma receives Chinese patent for naloxone sublingual film |
None |
| 2011-05-03 |
Boehringer Ingelheim, Eli Lilly receive FDA approval for Tradjenta to treat type 2 diabetes |
None |
| 2011-05-02 |
Watson introduces generic version of Concerta |
None |
| 2011-05-02 |
Watson launches Generess Fe low-dose oral contraceptives in the U.S. |
None |
| 2011-05-02 |
FDA accepts SGEN's brentuximab vedotin BLAs for Hodgkin lymphoma, ALCL treatment |
None |
| 2011-05-02 |
Assessment tool may help identify newborn exposure to methamphetamine |
None |
| 2011-05-02 |
Talecris, Grifols enter 'Consent Agreement' with FTC Staff |
None |
| 2011-05-02 |
Temsirolimus with chemotherapy may serve as promising therapy for mesothelioma |
None |
| 2011-05-01 |
Many herbal medicines banned under EU directives |
None |